Diagnostic Values of Serum Levels of Pepsinogens and Gastrin-17 for Screening Gastritis and Gastric Cancer in a High Risk Area in Northern Iran |
Nejadi-Kelarijani, Fatemeh
(Golestan Research Center of Gastroentrology and Hepatology, Golestan University of Medical Sciences)
Roshandel, Gholamreza (Golestan Research Center of Gastroentrology and Hepatology, Golestan University of Medical Sciences) Semnani, Shahryar (Golestan Research Center of Gastroentrology and Hepatology, Golestan University of Medical Sciences) Ahmadi, Ali (Department of Pathology, Tehran University of Medical Sciences) Faghani, Behzad (Department of Pathology, Tehran University of Medical Sciences) Besharat, Sima (Golestan Research Center of Gastroentrology and Hepatology, Golestan University of Medical Sciences) Akhavan-Tabib, Atefeh (Golestan Research Center of Gastroentrology and Hepatology, Golestan University of Medical Sciences) Amiriani, Taghi (Golestan Research Center of Gastroentrology and Hepatology, Golestan University of Medical Sciences) |
1 | Adamu MA, Weck MN, Rothenbacher D, Brenner H (2011). Incidence and risk factors for the development of chronic atrophic gastritis: five year follow-up of a population-based cohort study. Int J Cancer, 128, 1652-8. DOI |
2 | Cao Q, Ran ZH, Xiao SD (2007). Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin 17 and Helicobacter pylori immunoglobulin G antibodies. J Dig Dis, 8, 15-22. DOI ScienceOn |
3 | Copps J, Murphy RF, Lovas S (2009). The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers. Protein Pept Lett, 16, 1504. DOI |
4 | Correa P (1992). Human gastric carcinogenesis: a multistep and multifactorial process--first american cancer society award lecture on cancer epidemiology and prevention. Cancer Res, 52, 6735-40. |
5 | Dixon MF, Genta RM, Yardley JH, Correa P (1996). Classification and grading of gastritis. the updated sydney system. international workshop on the histopathology of gastritis, houston 1994. Am J Surg Pathol, 20, 1161-81. |
6 | Ghasemi Kebria F, Bagheri H, Semnani S, Ghaemi E (2011). Seroprevalence of anti-Hp and anti-cagA antibodies among healthy persons in Golestan province, northeast of Iran (2010). Caspian J Intern Med, 2, 256-60. |
7 | Iijima K, Abe Y, Kikuchi R, et al (2009). Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach. World J Gastroenterol, 15, 853-9. DOI ScienceOn |
8 | Kikuchi R, Abe Y, Iijima K, et al (2011). Low serum levels of pepsinogen and gastrin 17 are predictive of extensive gastric atrophy with high-risk of early gastric cancer. Tohoku J Exp Med, 223, 35-44. DOI ScienceOn |
9 | Lin SH, Li YH, Leung K, Huang CY, Wang XR (2014). Salt processed food and gastric cancer in a Chinese population. Asian Pac J Cancer Prev, 15, 5293-8. 과학기술학회마을 DOI |
10 | Lomba-Viana R, Dinis-Ribeiro M, Fonseca F, Vieira AS, et al (2012). Serum pepsinogen test for early detection of gastric cancer in a European country. Eur J Gastroenterol Hepatol, 24, 37-41. DOI |
11 | Miki K, Morita M, Sasajima M, et al (2003). Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol, 98, 735-9. DOI ScienceOn |
12 | Mansour-Ghanaei F, Joukar F, Baghaei SM, et al (2012). Gastric precancerous lesions in first degree relatives of patients with known gastric cancer: a cross-sectional prospective study in Guilan Province, north of Iran. Asian Pac J Cancer Prev, 13, 1779-82. 과학기술학회마을 DOI ScienceOn |
13 | Miki K, Ichinose M, Ishikawa KB, et al (1993). Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer. Jpn J Cancer Res, 84, 1086-90. DOI |
14 | Miki K, Ichinose M, Shimizu A, et al (1987). Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn, 22, 133-41. |
15 | Nasrollahzadeh D, Aghcheli K, Sotoudeh M, et al (2011). Accuracy and cut-off values of pepsinogens i, ii and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis. PLoS One, 6, 26957. DOI |
16 | Oishi Y, Kiyohara Y, Kubo M, et al (2006). The serum pepsinogen test as a predictor of gastric cancer. Am J Epidemiol, 163, 629-37. DOI ScienceOn |
17 | Rollan A, Ferreccio C, Gederlini A, Serrano C, Torres J, Harris P (2006). Non-invasive diagnosis of gastric mucosal atrophy in an asymptomatic population with high prevalence of gastric cancer. World J Gastroenterol, 12, 7172-8. |
18 | Roshandel G, Sadjadi A, Aarabi M, et al (2012). Cancer Incidence in Golestan Province: Report of an Ongoing Population-based Cancer Registry in Iran between 2004 and 2008. Arch Iran Med, 15, 196-200. |
19 | Shikata K, Ninomiya T, Yonemoto K, et al (2012). Optimal cutoff value of the serum pepsinogen level for prediction of gastric cancer incidence: the Hisayama Study. Scand J Gastroenterol, 47, 669-75. DOI |
20 | Shafaghi A, Mansour-Ghanaei F, Joukar F, et al (2013). Serum gastrin and the pepsinogen I/II ratio as markers for diagnosis of premalignant gastric lesions. Asian Pac J Cancer Prev, 14, 3931-6. 과학기술학회마을 DOI ScienceOn |
21 | Shiotani A, Iishi H, Uedo N, et al (2005). Histologic and serum risk markers for noncardia early gastric cancer. Int J Cancer, 115, 463-9. DOI ScienceOn |
22 | Vannella L, Lahner E, Annibale B (2012). Risk for gastric neoplasias in patients with chronic atrophic gastritis: A critical reappraisal. World J Gastroenterol, 18, 1279-85. DOI |
23 | Watabe H, Mitsushima T, Yamaji Y, et al (2005). Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut, 54, 764-8. DOI ScienceOn |
24 | Yanaoka K, Oka M, Mukoubayashi C, et al (2008). Cancer highrisk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males. Cancer Epidemiol Biomarkers Prev, 17, 838-45. DOI ScienceOn |
25 | Zheng RN, Li SR, Masahiro A (2012). Helicobacter pylori CagA and gastric carcinogenesis. Asian Pac J Cancer Prev, 13, 6305-10. 과학기술학회마을 DOI |
26 | Zhong C, Li KN, Bi JW, Wang BC (2012). Sodium intake, salt taste and gastric cancer risk according to Helicobacter pylori infection, smoking, histological type and tumor site in China. Asian Pac J Cancer Prev, 13, 2481-4. 과학기술학회마을 DOI ScienceOn |
27 | Kitahara F, Kobayashi K, Sato T, et al (1999). Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut, 44, 693-7. DOI ScienceOn |
![]() |